Metoprolol succinate and Paliperidone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoprolol succinate and Paliperidone. Common interactions include abdominal distension among females and schizophrenia among males.

The phase IV clinical study analyzes what interactions people who take Metoprolol succinate and Paliperidone have. It is created by eHealthMe based on reports of 23 people who take Metoprolol succinate and Paliperidone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

23 people who take Metoprolol succinate and Paliperidone together, and have interactions are studied.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 54,845 Metoprolol succinate users for its effectiveness, alternative drugs and more.

What is Paliperidone?

Paliperidone has active ingredients of paliperidone. eHealthMe is studying from 4,009 Paliperidone users for its effectiveness, alternative drugs and more.

Number of Metoprolol succinate and Paliperidone reports submitted per year:

Common Metoprolol Succinate and Paliperidone drug interactions by gender *:

female:

Abdominal distension
Anxiety
Coronary artery occlusion
Drug ineffective
Dyspnoea
Gastric ph increased
Gastrooesophageal reflux disease
Hiatus hernia
Insomnia
Myocardial infarction

male:

Schizophrenia
Drug resistance
Confusional state
Loss of consciousness
Paradoxical drug reaction
Gastric ulcer
Irritability
Pancreatitis
Tremor
Mental impairment

Common Metoprolol Succinate and Paliperidone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Schizophrenia
Asthenia
Confusional state
Loss of consciousness
Paradoxical drug reaction
Mental impairment
Drug resistance
Drug ineffective
Neuroleptic malignant syndrome
Insomnia

40-49:

n/a

50-59:

n/a

60+:

Myocardial infarction

Common conditions people have *:

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 19 people, 82.61%
Immunodeficiency Disorders: 4 people, 17.39%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and Paliperidone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.